Know the strengths and weaknesses of ischemia tests to guide the therapeutic strategy of a patient with multi-vessel disease

Int J Cardiol. 2016 Mar 1:206:64-7. doi: 10.1016/j.ijcard.2016.01.002. Epub 2016 Jan 15.

¹ Department of Cardiology, General Hospital Center, Chambery, France.
² Department of Radiology, University Hospital, Grenoble, France.
³ Department of Nuclear Medicine, General Hospital Center, Chambery, France.
⁴ INSERM U1039, Bioclinic Radiopharmaceutics Laboratory, Joseph Fourier University, Grenoble, France.
⁵ Department of Nuclear Medicine, University Hospital, Grenoble, France.
⁶ INSERM U1039, Bioclinic Radiopharmaceutics Laboratory, Joseph Fourier University, Grenoble, France; Department of Cardiology, University Hospital, Grenoble, France.
⁷ INSERM U1039, Bioclinic Radiopharmaceutics Laboratory, Joseph Fourier University, Grenoble, France; Department of Nuclear Medicine, University Hospital, Grenoble, France.
⁸ INSERM U1039, Bioclinic Radiopharmaceutics Laboratory, Joseph Fourier University, Grenoble, France; Department of Cardiology, University Hospital, Grenoble, France. Electronic address: [email protected].

No abstract available

Keywords: Cardiac magnetic resonance; Coronary artery disease; Fractional flow reserve; Single-photon emission tomography.

Publication types